Skip to main content
Clinical Trials/EUCTR2017-000278-13-FR
EUCTR2017-000278-13-FR
Active, not recruiting
Phase 1

Palatability testing in children of a new paediatric formulation of Racecadotril as oral suspension strawberry-flavored administered via an oral graduated syringe compared to the current formulation (apricot-flavored oral powder in sachet to be diluted).

BIOPROJET PHARMA0 sites40 target enrollmentMay 3, 2017

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Young healthy volunteers (7-12 years)
Sponsor
BIOPROJET PHARMA
Enrollment
40
Status
Active, not recruiting
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 3, 2017
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • \-Children, boys and girls, aged from 7 to 12 years in good health
  • \-Capable of performing the taste assessment, according to the investigator’s judgment
  • \-Willing to participate to the taste assessment and to give his (her) assent in writing after a process of appropriate information according to his (her) capacity of understanding
  • \-The informed consent of the parent or legal representative should be obtained for the participation of his(her) child
  • \-Parent or legal representative, in good health, capable of performing the taste assessment and having signed the specific informed consent for his(her) own participation
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 40
  • F.1\.2 Adults (18\-64 years) no
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) no

Exclusion Criteria

  • For the 2 populations, adult and children
  • \-Previous history of sensitivity or allergy to the active substance or any medicinal products or excipients
  • \-Subjects with rare hereditary problems of fructose intolerance, glucose\-galactose malabsorption syndrome or saccharase\-isomaltase deficiency
  • \-Presence of any condition that could influence taste sensations within the 5 days before the test (upper respiratory infection, fever, buccal mucositis, aphtous ulcers)
  • \-Intake within the 4 hours preceeding the test of substances that could interfere with taste sensation (highly spiced meals, mint or menthol – based products, chewing\-gums)
  • Specific for children
  • \-Child incapable, according the investigator’s opinion, to perform the test as planned in the protocol (to keep the product in the mouth without swallowing and then spit it out) and/or to express his (her) own taste impression
  • \-Child has not given his (her) assent to participate or informed consent was not obtained from the parent

Outcomes

Primary Outcomes

Not specified

Similar Trials